Versus EmtricitabinePlus TDF - HIVandHepatitis.com
Versus EmtricitabinePlus TDF - HIVandHepatitis.com
Versus EmtricitabinePlus TDF - HIVandHepatitis.com
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Summary of Safety Data<br />
<strong>TDF</strong><br />
(N=53)<br />
FTC/<strong>TDF</strong><br />
(N=52)<br />
Adverse Event, Patients with<br />
Grade 3 or 4 AE 1 (2%) 4 (8%)<br />
SAE (one considered related to study drug: ALT<br />
flare*)<br />
6 (11%) 10 (19%)<br />
AE that resulted in DC 0 0<br />
Death (Pulmonary cancer with osseous metastasis) 0 1 (2%)<br />
Laboratory Abnormalities, Patients with<br />
Grade 3 or 4 laboratory abnormality 10 (19%) 12 (23%)<br />
Grade 4 ALT (>10 x ULN) and > 2 x Baseline* 0 2 ( 4%)<br />
Confirmed ≥0.5 mg/dL increase in creatinine 0 0<br />
Confirmed CrCl decline to
Change language